News

Zacks.com on MSN12h

Pfizer Oncology Drugs Drive Sales in Q2: Will the Trend Continue?

Oncology sales comprise more than 25% of Pfizer’s total revenues. Its oncology revenues grew 9% in the first half of 2025, ...
Zacks Investment Research on MSN10h

MRK's ADC Candidate Gets FDA Breakthrough Therapy Tag for Lung Cancer

Merck MRK announced that the FDA has granted the Breakthrough Therapy designation (BTD) to its B7-H3-directed DXd ...